nbp1 39681 Search Results


neuronal nitric oxide synthase  (Novus Biologicals)
93
Novus Biologicals neuronal nitric oxide synthase
Impact of Cc Pretreatment on Ventromedial Hypothalamus Nucleus (VMN) AMPK and, Glutamate Decarboxylate65/67 (GAD65/67), <t>and</t> <t>Neuronal</t> Nitric Oxide <t>Synthase</t> (nNOS) Protein Expression during Insulin-Induced Hypoglycemia (IIH). Results show mean normalized VMN AMPK (Panel A), pAMPK (Panel B), GAD65/67 (Panel C), and nNOS (Panel D) O.D. values + S.E.M. for V/V, V/INS, and Cc/INS treatment groups (n=5/group). *p<0.05; **p<0.01; ***p<0.001.
Neuronal Nitric Oxide Synthase, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nbp1+39681/nNOS+Antibody/pmc06309468-60-45-52
Average 93 stars, based on 1 article reviews
neuronal nitric oxide synthase - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
nbp1 39681  (Novus Biologicals)
93
Novus Biologicals nbp1 39681
Impact of Cc Pretreatment on Ventromedial Hypothalamus Nucleus (VMN) AMPK and, Glutamate Decarboxylate65/67 (GAD65/67), <t>and</t> <t>Neuronal</t> Nitric Oxide <t>Synthase</t> (nNOS) Protein Expression during Insulin-Induced Hypoglycemia (IIH). Results show mean normalized VMN AMPK (Panel A), pAMPK (Panel B), GAD65/67 (Panel C), and nNOS (Panel D) O.D. values + S.E.M. for V/V, V/INS, and Cc/INS treatment groups (n=5/group). *p<0.05; **p<0.01; ***p<0.001.
Nbp1 39681, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nbp1+39681/nNOS+Antibody/pm36409024-90-1-3
Average 93 stars, based on 1 article reviews
nbp1 39681 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

Image Search Results


Impact of Cc Pretreatment on Ventromedial Hypothalamus Nucleus (VMN) AMPK and, Glutamate Decarboxylate65/67 (GAD65/67), and Neuronal Nitric Oxide Synthase (nNOS) Protein Expression during Insulin-Induced Hypoglycemia (IIH). Results show mean normalized VMN AMPK (Panel A), pAMPK (Panel B), GAD65/67 (Panel C), and nNOS (Panel D) O.D. values + S.E.M. for V/V, V/INS, and Cc/INS treatment groups (n=5/group). *p<0.05; **p<0.01; ***p<0.001.

Journal: Brain research bulletin

Article Title: Hindbrain Dorsal Vagal Complex AMPK Controls Hypothalamic Gluco-regulatory Transmitter and Counter-Regulatory Hormone Responses to Hypoglycemia

doi: 10.1016/j.brainresbull.2018.11.016

Figure Lengend Snippet: Impact of Cc Pretreatment on Ventromedial Hypothalamus Nucleus (VMN) AMPK and, Glutamate Decarboxylate65/67 (GAD65/67), and Neuronal Nitric Oxide Synthase (nNOS) Protein Expression during Insulin-Induced Hypoglycemia (IIH). Results show mean normalized VMN AMPK (Panel A), pAMPK (Panel B), GAD65/67 (Panel C), and nNOS (Panel D) O.D. values + S.E.M. for V/V, V/INS, and Cc/INS treatment groups (n=5/group). *p<0.05; **p<0.01; ***p<0.001.

Article Snippet: Proteins of interest were probed with primary polyclonal antisera raised in rabbit against AMPK α1/2 (1:2,000; 2532s; Cell Signaling Technology, Danvers, MA), pAMPK α1/2 (Thr 172; 1:2,000; 2535; Cell Signaling Technol.), RFamide related peptide-1 (RFRP-1; 1:1,000, sc-67010; Santa Cruz Biotechnology, Inc., Santa Cruz, CA), or neuronal nitric oxide synthase (nNOS; 1:2,000, NBP1–39681; Novus Biologicals, LLC, Littleton, CA), or raised in goat against NPY (1:2,500, NBP1–46535; Novus Biol.), POMC (1:2,000, NB100–1533; Novus Biol.), GAD 65/67 (1:2,000, AB1511; EMD Millipore, Burlington, MA), RFamide related peptide-3 (RFRP-3; 1:1,000, sc-32380; Santa Cruz Biotechnol.), or ORX-A (1:1,000, sc-8070; Santa Cruz Biotechnol.).

Techniques: Expressing